Symposium Posters

The 2021 NETRF Virtual Research Symposium was held online on October 11-15, 2021. The meeting had over 300 attendees and included close to 60 presentations by NET researchers from around the world. Thirty-two posters were presented and grouped into the same four sessions based on NET type as were the oral presentations. Please note that some presenters chose not to post their presentations online following the meeting and have been respectfully omitted here.

  • Session 1. Gastrointestinal NETS
  • Session 2. Multiple NETs
  • Session 3. Pheochromocytoma and Paraganglioma
  • Session 4. Pancreatic NETs

Short videos of the author presenting their work may be viewed here and the abstracts and posters may be downloaded.  Please click on any of the posters you would like to see and use the filters to search for specific ones based on the session topic or the presenting author’s last name. If you wish to change search filters, reset it to ‘Select’ before switching.

To view Symposium talks, visit the Symposium Videos webpage by Clicking Here.

Search by Session or by Name

Select Session

The Wnt signaling protein Dishevelled targets Somatostatin Receptor 2 for lysosomal degradation

Presenter: Carr

The impact of SARS CoV2 pandemic on PRRT in neuroendocrine patients: one year experience in an ENETS certified center

Presenter: Grana

Peptide photosensitizer conjugates for implementation in GLP1R and SSTR targeted photodynamic therapy of neuroendocrine tumors

Presenter: Van Lith

Meaningful progress in the therapy of neuroendocrine cancers, needs rigorous interpretation of data and balanced trial designs

Presenter: Fojo

Identifying Mechanisms Of Sensitivity And Resistance In Response To LuTate PRRT

Presenter: Waldeck

Hyperammonemiais an underdiagnosed prognostic complication in neuroendocrine neoplasm patients with liver metastases

Presenter: Refardt

Gold Coated Nanoparticles as a vehicle for 225Ac/89Zr delivery for use as a Theragnostic Agent in Targeted a-Therapy

Presenter: Diehl

Generating neuroendocrine tumor models to build a disease specific dependency map

Presenter: Atari

Drug Combinations to Harness Metabolic Stress in the Therapy of Neuroendocrine Tumors

Presenter: Bates

Discordance between central versus local response assessments in neuroendocrine tumor (NET) patients (pts) enrolled in A021202

Presenter: Geyer